X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOLOGY

期刊標題檢索 ONCOLOGY-BASEL 最新評論: Can you continue to update your process? (2024-05-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOLOGY]您好,您是該頁面的第 59616 位訪客。

期刊簡介
期刊名稱ONCOLOGY ONCOLOGY
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
5.0

Speed
7.0

期刊簡稱ONCOLOGY-BASEL
ISSN0030-2414
E-ISSN1423-0232
h-index92
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.000.8320.783
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2130 / 404
Category: Medicine
Subcategory: Cancer Research
Q2108 / 230

自引率 (2023-2024)4.00%自引率趨勢
掲載範囲
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
官方網站http://www.karger.com/Journal/Home/223857
在線稿件提交http://oper1.karger.com/journals/default.asp?ProduktNr=223857
開放訪問No
出版商S. Karger AG
主題領域医学
出版國/地區SWITZERLAND
發行頻率隔月刊行
創刊年1967
每年文章數129每年文章數趨勢
黃金OA百分比19.87%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3183/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0030-2414%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330757
    CANCER RESEARCH312132
    BMC CANCER245463
    Asian Pacific Journal of Cancer Prevention219099
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198013
    INTERNATIONAL JOURNAL OF CANCER191611
    CLINICAL CANCER RESEARCH181653
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176246
    ONCOLOGY REPORTS174993
    CA-A CANCER JOURNAL FOR CLINICIANS163630
  •  

    ONCOLOGY ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [ONCOLOGY] 的評論撰寫評論
作者: 北冥和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 11:14:25 評論於
Can you continue to update your process?
(0) 讚! | 北冥和同

作者: 苏珊威廉姆斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 10:20:22 評論於
Is the number of pages exceeded?
(0) 讚! | 苏珊威廉姆斯

作者: 晓霜姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 15:12:33 評論於
How long is your review process?
(0) 讚! | 晓霜姑娘

作者: 北冥和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 08:50:43 評論於
Not OA, but with page change
(0) 讚! | 北冥和同

作者: 稻妻尔白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-19 23:56:34 評論於
Why do I have to pay to have my article published after it has been accepted by the publisher? Isn't this a non-OA journal?
(0) 讚! | 稻妻尔白

作者: 雾都从露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-16 14:46:19 評論於
The website simply won't open
(0) 讚! | 雾都从露

作者: 通幽寄竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-10 19:26:06 評論於
Please translate the following paragraph into English and Japanese, respectively, with the titles ":" and ":": https://ocl.manuscriptmanager.net/                                        
https://karger.com/ocl/pages/guidelines
(0) 讚! | 通幽寄竹

作者: 通幽寄竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-10 15:21:18 評論於
Submit to Oncology on May 4th (5th
(0) 讚! | 通幽寄竹

作者: 通幽寄竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-09 08:01:22 評論於
5-4 (5-5) Submitt to Oncology
5-5 Pre-evaluation
5-9 Resent for "consent statement"
5-10 In review (not "Under review"
(0) 讚! | 通幽寄竹

作者: 通幽寄竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-05 15:41:35 評論於
No need. However, before submitting, they require a language check through a word processing software, for which an online payment is needed. If your writing is fine, you can proceed to the regular submission stage
(0) 讚! | 通幽寄竹

作者: 通幽寄竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-05 13:07:09 評論於
Re-enter the publishing house, search for Oncology, and then click "submit" again. Enter the username and password you used when submitting before (sign in), then click on the author box (this will take you to your dashboard where your article is already displayed. Of course, you can also submit a new article ;-
(0) 讚! | 通幽寄竹

作者: 绮山大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 19:10:20 評論於
Hello, do you need to pay the submission fee for this magazine?
(0) 讚! | 绮山大叔

作者: 绮山大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-27 19:17:02 評論於
Does this magazine require submission fees?
(0) 讚! | 绮山大叔

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:53:15 評論於
The discussion section is the core part of an SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Different articles and authors will have different word counts for the discussion section, ranging from a few thousand words to tens of thousands of words
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:57:17 評論於
Is the lengthy discussion showing the author's reflections on the topic? How did the reviewer perceive the manuscript?
(0) 讚! | 平原文波

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 11:27:58 評論於
What is IF?
(0) 讚! | 平原文波

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-16 16:45:43 評論於
Review speed: 2.0 | Submission success rate: 50.0 Experience sharing: Not friendly to Chinese people, too many instant rejections!! Chinese articles only account for 2%
(0) 讚! | 法慧和同

作者: 法慧筱萌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-02-28 21:37:20 評論於
Were you able to check later?
(0) 讚! | 法慧筱萌

作者: 沛雯mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-02-23 20:56:03 評論於
Review Speed: 1.0 Experience Sharing: I read comments saying that the review process is fast, but very few papers from China are accepted, so I had little hope. I decided to give it a try anyway. I spent some time reading the submission requirements and finally submitted my paper. I submitted it in the morning, and in the afternoon I received a message saying that my paper was under review. Surprisingly, at 2am, my paper was rejected. It was so fast, I'm not sure if they were not interested in the paper or China
(0) 讚! | 沛雯mm

作者: 飞龙浩旷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-09 09:07:13 評論於
How can I check the submission status? Why can't I check it at all after submitting?
(0) 讚! | 飞龙浩旷

作者: 无极浩淼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-09-06 14:46:28 評論於
The submission was rejected the next day, quite fast. An efficient journal
(0) 讚! | 无极浩淼

作者: 书生曼凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-05-26 08:01:32 評論於
Is there an address for submission? I searched for a long time but I don't know how to submit
(0) 讚! | 书生曼凡

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-10 23:28:54 評論於
The efficiency is too high. Submitted at noon, and after three or four hours, the manuscript is already under review. I went to bed at around eleven o'clock in the evening, and when I checked the status, it was already rejected – rejected instantly. The rejection letter didn't come until the next day
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-09 14:43:52 評論於
It's only been a few hours since I submitted, and it's already under review? That was fast!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 18:51:30 評論於
Bullish, if it goes up a little more tomorrow, there is a chance to break through 3 points
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*